Tag Archives: BioNTech

Berlin, German |  Xinhua |  German developer and manufacturer of active immunotherapies BioNTech on Monday posted a loss of 190 million euros (209 million U.S. dollars) in the second quarter of 2023 as demand for its COVID-19 vaccine waned. In the same period last year, the company made a profit …

Pfizer and BioNTech to test a candidate | THE INDEPENDENT | Pfizer and BioNTech announced a new clinical trial for universal COVID-19 vaccine candidates.They say the candidates will include T-cell enhancing shots and pan-coronavirus shots that “protect against the broader family of viruses and its mutations.” A key challenge for …

How drug industry is undermining WHO plans | TIMOTHY HUZAR | Since June 2021, the WHO has been coordinating a messenger ribonucleic acid (mRNA) vaccine technology transfer hub in South Africa. The hub is important because it will increase the availability of mRNA vaccines, including those for COVID-19, in Africa, …

Berlin, Germany | Xinhua | German biotechnology company BioNTech and U.S. company Pfizer have started clinical trials of an Omicron-based COVID-19 vaccine candidate in healthy adults 18 through 55 years of age, the companies said on Tuesday. The trials would evaluate the safety, tolerability and immunogenicity of the vaccine candidate, according …

New York, U.S. | Xinhua | A booster shot of COVID-19 vaccine would provide enough protection against the Omicron variant while two doses may not be sufficient, said COVID-19 vaccine developers Pfizer Inc. and BioNTech SE on Wednesday. Three doses of the Pfizer-BioNTech COVID-19 vaccine would generate sufficient serum antibodies to …

New York, U.S. | Xinhua | Drugmakers Pfizer and BioNTech said on Tuesday that they had asked the U.S. Food and Drug Administration (FDA) to authorize booster shots of their COVID-19 vaccine for all adults 18 years old and over, seeking to broaden who is eligible for a third shot. The …

Berlin, Germany | Xinhua | A booster vaccination with the COVID-19 vaccine of BioNTech and Pfizer increased protection to up to 95.6 percent, the companies announced on Thursday. A randomized, controlled phase III study of more than 10,000 people aged 16 years and older found that booster vaccinations with the Comirnaty …

BioNTech affirmed its intention to manufacture any vaccines arising from its development of vaccine candidates to fight malaria and tuberculosis on the African continent Berlin, Germany | THE INDEPENDENT | President Paul Kagame of Rwanda, President Macky Sall of Senegal, President Ursula von der Leyen of the European Commission and …

Washington, U.S. | Xinhua | Pfizer and BioNTech said they are developing a COVID-19 booster shot intended to target the highly transmissible Delta variant, according to U.S. media reports on Thursday. Concerns continue to rise as the Delta strain has already become the dominant variant in the United States, causing increasing …

  Berlin, Germany | Xinhua | German biotechnology company BioNTech and U.S. company Pfizer have submitted a request to the European Medicines Agency (EMA) for the approval of an extension of their COVID-19 vaccine use in adolescents aged 12 to 15, the two companies announced on Friday. The submission was based on …